Академический Документы
Профессиональный Документы
Культура Документы
Source: Fryslan0109
1
Making an Impact: Impact Investing and
the Future of Finance
By: Jacob Scott 20
A Note From the Editor: Enter Elevar Equity, a venture capital firm. Now, when one thinks
On Behalf of the Colgate Finance Club, we are
of venture capital, he or she is typically inclined to imagine an
pleased to present to you the Fall 2017 Edition of eccentric billionaire investing in promising technology startups in
the Colgate Finance Club Journal. Silicon Valley, raking in millions when those firms go big. And
The student contributors to this publication there may be a grain of truth to that.
have worked tirelessly on their articles. We are
However, Elevar Equity does not fit that stereotype. That is because
extremely proud of each authors piece and
hope you find them accurate and informative.
Elevar Equity is a participant in the burgeoning field of what is
Educating the Colgate Community about the called impact investing. And it is through this impact investing that
financial markets is the core mission of our club the firm has been the driving force behind the positive outcomes
and this publication allows us to make our goal outlined above.
achievable.
Impact investing, as defined by the Global Impact Investment
Again, I would just like to reiterate our appreci-
ation for all involved in the creation of the Jour-
Network, is when investments are made into companies,
nal. Without the help of the writers, administra- organizations, and funds with the intention to generate social and
tion, and alumni, this would not be possible. As environmental impact alongside a financial return (1). It is a simple
always, Go Gate! yet incredibly powerful concept; rather than individuals or firms
Sincerely, making investments based purely on financial return, benchmarks
Chad Zappia 20 of social benefit and positive environmental impact are just as
crucial in judging the viability and success of the investments.
President, Colgate Finance Club
Chief Editor, Colgate Finance Club Journal That is exactly the method of assessment that a firm like Elevar
Equity utilizes. When it makes its investments, it takes into
2
account, in its unique case, the social impact of democratizing access to goods, services, and markets
previously inaccessible to the customers and entrepreneurs that it serves (2). It does this while at the same
time generating at-market and even above-market financial returns.
That is not only impressive, but, if replicable, could be game changing. Heres why.
There are some 37 trillion dollars worth of assets under management in the United States alone (3). With
pressing social needs around the world (and indeed in the United States as well), unlocking even just a
portion of these trillions of dollars through impact investing could give rise to profound positive change.
With a mere .0002% of these resources, a firm like Elevar Equity was able to impact the lives of millions. If
even just 1% of assets under management in the United States were deployed in impact investing it would be
monumental, and could positively impact tens or even hundreds of millions of people.
However, despite this immense potential, it is still a very new field facing systematic challenges. One
challenge is the newness itself. The term impact investing wasnt even coined until 2007, and is only just
beginning to be practiced on a semi-large scale (4). And even if it can consistently produce financial returns,
it is nonetheless still a new and unfamiliar field for the vast majority of investors, who typically prefer known
risks to unknown ones. This presents a particularly difficult challenge, as investors are hesitant to act until
the investment products and opportunities have proven track records; however, these investment products
and opportunities cannot develop proven track records due to the hesitancy of the investors.
Another related challenge is that of insufficient data. While there are a variety of compelling anecdotes and
stories about impact investing and its ability to generate profit and social benefit, there is a lack of accessible
and reliable data on the breadth, successes, and potential of the field. What is more, there is insufficient
transparency, disclosure, and standardization of data among not only the firms that are making the impact
investments but also among the entrepreneurs and organizations receiving them (5).
However, there is reason yet to be optimistic. Venture capital too, before it was a proven asset class, had great
difficulty in going mainstream. However, once institutional players like pension funds began investing, the
field rapidly became acceptable and attractive to global investors. And with developments like the Ford
Foundation dedicating 1 billion dollars to impact investing over the next ten years, the same mainstreaming
that happened with venture capital may come to impact investing. This is especially true given the work of
groups like the Case Foundation, who are working to develop data tools like an Impact Investing Network
Map. Given these developments and barring something catastrophic like another financial collapse, it is only
a matter of time until other major institutional players begin to get on board (6).
Ultimately, if this method of finance grows, it could result in a mass of positive effects. Aligning the
incentives of a wide breadth of stakeholders, could systematically address issues such as housing, lack of
access to capital, poverty, and deforestation, while at the same time generating financial returns. With this,
impact investing could join models and institutions such as participatory budgeting, community
development financial institutions, and public banking in the transformation of the world of finance from
both an extractive destabilizer of the economy and accelerator of inequality to an integrated stabilizer
promoting human development and wellbeing.
simplifying IT
3
Amazon Versus the Retail Industry
By: Tony Hong 21
Amazon, the tech giant best known for its online shopping platform, has clawed for more market share since
its inception. Recent moves by management, however, have been particularly aggressive; Most notably, its
acquisition of grocery chain Whole Foods this August has caused severe alarm and agitation among its com-
petitors. With the company refining its existing services as well as expanding into new territory (literally and
figuratively), many fear a so-called retail apocalypse. While Amazon is certainly a significant threat to retail-
ers, there are several factors that can inhibit its power.
For much of its existence, Amazon has charged low prices. This is because Amazon is able to avoid state sales
taxes on its goods, due to its lack of physical facilities (1). This precedent was established in a 1992 Supreme
Court case, Quill Corp. v. North Dakota, in which the Court citing the Commerce Clause decided that
state sales taxes can only be imposed on companies that have a physical presence (nexus) in the state; how-
ever, as the business expanded, it was forced to build physical locations around the country (warehouses,
etc.). This phenomenon was necessitated by the companys offering of same-day and next-day delivery op-
tions. Although there is still a loophole - third-party vendors who sell via Amazon still do not charge a sales
tax - there is increasing backlash against this, from both competitors as well as others, such as state Senator
Roger Chamberlain of Minnesota (2). Essentially, the competitiveness of Amazons prices may be more tem-
porary than one would think.
Furthermore, retailers are striving to match Amazons aggressive expansion. As Mad Money host Jim
Cramer explains, The only way to beat Amazon is by becoming more like Amazon (3). Walmart, an equally
intimidating behemoth of the retail sector, said that it plans to open 255 new stores internationally over the
course of the next two years (4). Others, such as Ralph Lauren, are focusing on improvements to their e-
commerce platforms, believing that the user-friendly Amazon interface is a strong contributor to the compa-
nys success (3). Perhaps drawing inspiration from the tech giant, Costco now offers same-day deliveries in
over half of its locations, with plans to expand this service (5). Target is attempting to take user convenience
to the next level with voice-activated shopping from smartphones (6).
Clearly, retailers will not bow to Amazon. The same shopping features that attracted such a huge customer
base - convenience, variety, user friendliness - are being implemented by competitors. While the stock mar-
ket by itself may seem to indicate that Amazon is crushing other retailers, initiatives by the companies man-
agement teams indicate that a highly competitive retail environment is ahead.
simplifying IT
5
explosion in funding and innovation has drawn many new investors into the cryptocurrency space, and has
propelled it into the public spotlight. Another theory was that demand from Asia, particularly from Japan and
Korea, was what first propelled Bitcoin in the early stages of the rally (7). A looser regulatory environment in
those countries, combined with a budding cryptocurrency mania, pushed the price of Bitcoin on Korean and
Japanese exchanges well above the dollar-denominated price. Regardless of what sparked Bitcoins initial rise,
once it started reaching all-time highs in early 2017, the media and public began to take notice, and awareness
of Bitcoin increased massively, which has since helped to push the price up even further (8).
Right now, the million-dollar question (literally) seems to be what will happen to Bitcoin and its price in the
future? Although many reporters, bankers, and pundits have called Bitcoins rise a bubble, and have done so
for many months now (9), there are no signs that Bitcoins rally will cool off anytime soon. The more im-
portant question is what will happen to the Bitcoin protocol and the concept of blockchain in general? The
increased press coverage has helped to boost public awareness of Bitcoin, and more institutions have ex-
pressed eagerness to integrate blockchain technology into their operations; however, Bitcoin itself still has a
long way to come. The community is currently locked in an intense debate over the best way to scale the
Bitcoin network to handle increased transaction volume, and only a limited number of retailers currently ac-
cept the digital currency. Will Bitcoin eventually replace the dollar? Only time will tell.
Source: FreeGreatPicture.com
simplifying IT
6
Mylans Controversial EpiPen
By: Jessica Kern 20
Over the past few years, Mylan Pharmaceuticals has been under national attention for the price of its infa-
mous EpiPen; when injected, it will stop a potentially fatal allergic reaction. Mylan received national backlash
when the price of EpiPens soared to over $600 in early 2016 for a pack of two one-time injectables, increasing
from the original price of $100 per two pens back in 2007 when Mylan first took over ownership rights of the
product from Merck KGaA (1).
A major reason Mylan was able to raise the price of the EpiPen without losing consumers is due to the patent
it has for the EpiPen through 2025. The patent protects Mylans EpiPen design which injects the drug, rather
than having the patent on the fairly common epinephrine drug used. This ensures Mylan is the only company
with the right to distribute EpiPens and no other company can produce a product with a similar design (2).
This makes it so that other companies have a difficult time entering the market with substitute goods for the
EpiPen. Because competing pharmaceutical companies must create a product with a fundamental difference
in design than the EpiPen, these products must receive FDA approval before hitting the market, which can be
difficult and time consuming (2). This was the case when another pharmaceutical company, Teva Pharmaceu-
tical Industries, tried to create another product with the ability to inject epinephrine which would compete
directly with the EpiPen. The FDA prevented Tevas product from hitting the market citing it had major defi-
ciencies with the design, specifically believing the design would be difficult to use in dire and stressful events,
such as an allergic reaction (3). In many cases, such as the EpiPen, patents allow for a company to have sole
production rights over a certain drug for a period of time, which can lead to drastic increases in prices of life
saving drugs; however, some argue that patents are a necessity for medical advances, citing the high profits
for a medical breakthrough gives companies the incentive to invest large amounts of money in research .
While Mylans patent allowed it to have sole production rights of the EpiPen, United States antitrust laws
prevent Mylan from acting as a monopolist for the product. In late 2016, Mylan settled a $465 million lawsuit
with the U.S. Department of Justice for acting as a monopolist and overpricing the EpiPen (4). In the lawsuit,
it was presented that it costs Mylan about $34.50 to produce a single EpiPen, which injects $1 worth of the
drug epinephrine (5). While the original EpiPen has not received a drastic price since the lawsuit was settled,
Mylan has started producing a generic version of the EpiPen, selling at $300 per two pack. Furthermore, CVS
has received FDA approval for a generic product called Adrenaclick with a similar purpose to the EpiPen, sell-
ing at just $10 per two pack (6).
Mylans unethical economic practices with the EpiPen was not an isolated event for the company, or even the
pharmaceutical industry as a whole. Mylan, along with 17 other pharmaceutical drug companies are currently
facing a lawsuit from 45 U.S. state attorneys alleging these companies have engaged in price fixing (3). Price
fixing occurs when a group of companies simultaneously agree to higher prices above the current or market
equilibrium price. If enough companies take part in price fixing it can be very effective because consumers
have little to no options at the lower, unfixed price. This investigation is still ongoing. With the affordability
simplifying IT
7
and access to drugs these companies produce being the difference between life and death in certain situa-
tions, it is time as a society to discuss whether our current regulations on drug companies are effective
enough to protect the consumer, and not simply focus on profit maximization for pharmaceutical companies.
Source: Wikipedia.com
Citations
Making an Impact: Impact Investing and the Future of Finance
1. https://thegiin.org/impact-investing/need-to-know/#s8
2. https://www.elevarequity.com/about/
3. http://www.lifteconomy.com/blog/2017/2/5/fran-seegull-investing-in-private-social-enter prise-for-deep-impact
4. https://www.rockefellerfoundation.org/our-work/initiatives/innovative-finance/
5. https://ssir.org/articles/entry/data_the_next_frontier_for_impact_investing
6. https://ssir.org/articles/entry/data_the_next_frontier_for_impact_investing
1. http://www.businessinsider.com/amazon-sales-tax-walmart-2017-10
2. http://money.cnn.com/2017/03/29/technology/amazon-sales-tax/index.html
3. https://www.cnbc.com/2017/08/08/cramer-retailers-are-finally-starting-to-buck-amazons-takeover.html
4. http://marketrealist.com/2017/11/analysts-expect-walmarts-fiscal-3q18-sales-rise/
5. http://www.businessinsider.com/costco-delivery-options-vs-amazon-2017-10
6. http://www.nasdaq.com/article/here-are-factors-influencing-targets-tgt-upcoming-q3-earnings-cm876639
1. https://charts.bitcoin.com/chart/price
2. https://bitcoin.org/bitcoin.pdf
3. https://www.paypal-community.com/t5/My-Feedback-for-PayPal-Archive/Why-Does-PayPal-Allow-Chargeback-Fraud/td-p/658022
4. https://coinmarketcap.com/
simplifying IT
8
6. https://qz.com/1004892/the-bancor-ico-just-raised-153-million-on-ethereum-in-three-hours/
7. https://www.cnbc.com/2017/08/12/bitcoin-vaults-to-new-record-above-4k-boosted-by-japan-and-multiplying-its-value-fourfold.html
8. https://www.coindesk.com/reasons-behind-bitcoins-price-media-hype/
9. https://www.bloomberg.com/news/articles/2017-11-29/for-bitcoin-skeptics-the-question-is-what-will-pop-this-bubble
1. https://www.theatlantic.com/health/archive/2016/08/epi-pens/497126/
2. https://www.statnews.com/2016/09/09/epipen-lack-of-innovation/
3. https://www.usatoday.com/story/money/2017/10/31/mylan-generic-drug-fixing-lawsuit/817859001/
4. https://www.nytimes.com/2016/10/08/business/epipen-mylan-justice-department-settlement.html?ref=topics&_r=0
5. https://www.nbcnews.com/business/consumer/mylan-says-it-upgraded-epipen-2009-so-experts-looked-inside-n652651
6. https://www.consumerreports.org/drug-prices/epipen-alternative-that-costs-just-10-dollars/
Members of the Colgate Finance Club meeting with alumni at BNP Paribas in New York City